PROM1 and non-small cell lung carcinoma: In a study titled “Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry” (32) the authors investigated biopsies of 305 cases of NSCLC, including 210 squamous cell carcinoma and 95 adenocarcinoma, to determine the impact of VM on OS.